{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:49:58Z","timestamp":1770068998127,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jlr.2023.100340","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T01:49:37Z","timestamp":1675388977000},"page":"100340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-0406","authenticated-orcid":false,"given":"Mohammad Nazmul","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Matye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2518-9519","authenticated-orcid":false,"given":"Lijie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung Dai","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiangang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2023.100340_bib1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jlr.2023.100340_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A\u00a0regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jlr.2023.100340_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2023.100340_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2016.01.016","article-title":"Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid","volume":"64","author":"Ijssennagger","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib6","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/hep4.1980","article-title":"Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study","volume":"6","author":"Loomes","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jlr.2023.100340_bib8","article-title":"Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases","volume":"3","author":"Sanyal","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jlr.2023.100340_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep4.1209","article-title":"NGM282 for treatment of patients with Primary Biliary Cholangitis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jlr.2023.100340_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A\u00a0randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcmgh.2021.04.013","article-title":"Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental nonalcoholic steatohepatitis","volume":"12","author":"Matye","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"Benefit of adding ezetimibe to statin therapy on Cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: vytorin Efficacy International Trial)","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jlr.2023.100340_bib14","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A\u00a0human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib17","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.jlr.2022.100261","article-title":"Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury","volume":"63","author":"Truong","year":"2022","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jlr.2023.100340_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-2275(20)38331-0","article-title":"Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions","volume":"30","author":"Heuman","year":"1989","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmgh.2020.12.004","article-title":"Cholangiopathy and biliary fibrosis in Cyp2c70-deficient mice are fully reversed by ursodeoxycholic acid","volume":"11","author":"de Boer","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MOG.0000000000000805","article-title":"Cellular senescence in the cholangiopathies","volume":"38","author":"Bogert","year":"2022","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jlr.2023.100340_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfl050","article-title":"Tissue distribution and ontogeny of sulfotransferase enzymes in mice","volume":"93","author":"Alnouti","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jlr.2023.100340_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/toxsci\/kfx078","article-title":"Sortilin 1 loss-of-function protects against cholestatic liver injury by attenuating hepatic bile acid accumulation in bile duct ligated mice","volume":"161","author":"Li","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jlr.2023.100340_bib24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1124\/dmd.30.9.997","article-title":"Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes","volume":"30","author":"Duanmu","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jlr.2023.100340_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib26","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1152\/physrev.00054.2017","article-title":"Guts and gall: bile acids in regulation of intestinal epithelial function in Health and Disease","volume":"98","author":"Hegyi","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jlr.2023.100340_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.jlr.2023.100340_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.ATV.0000067702.22390.20","article-title":"Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jlr.2023.100340_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0022-2275(20)37819-6","article-title":"Changes in biliary and fecal bile acids in mice after treatments with diosgenin and beta-sitosterol","volume":"25","author":"Uchida","year":"1984","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0016-5085(79)80079-7","article-title":"Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria","volume":"77","author":"Fedorowski","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jlr.2023.100340_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-6968.2004.tb09568.x","article-title":"Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces","volume":"235","author":"Lepercq","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.jlr.2023.100340_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/microorganisms9030469","article-title":"Microbial Hydroxysteroid Dehydrogenases: from Alpha to Omega","volume":"9","author":"Doden","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jlr.2023.100340_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2191-219X-3-60","article-title":"Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT","volume":"3","author":"Padmanabhan","year":"2013","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.jlr.2023.100340_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cell.2015.08.059","article-title":"Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel","volume":"163","author":"Dey","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2023.100340_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/pro.3599","article-title":"Structural and functional characterization of a novel acidophilic 7alpha-hydroxysteroid dehydrogenase","volume":"28","author":"Tang","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.jlr.2023.100340_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep22885","article-title":"The three-dimensional structure of Clostridium absonum 7alpha-hydroxysteroid dehydrogenase: new insights into the conserved arginines for NADP(H) recognition","volume":"6","author":"Lou","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2023.100340_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BJ20110022","article-title":"Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1","volume":"436","author":"Odermatt","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.jlr.2023.100340_bib38","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib41","article-title":"Circulating FGF19 closely correlates with bile acid synthesis and cholestasis\u00a0in patients with primary biliary cirrhosis","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2023.100340_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/bj2800373","article-title":"Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats","volume":"280","author":"Dueland","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.jlr.2023.100340_bib43","article-title":"Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition","volume":"1867","author":"Li","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jlr.2023.100340_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jhep.2020.03.024","article-title":"Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study","volume":"73","author":"Newsome","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jlr.2023.100340_bib45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice","volume":"1","author":"Zhou","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jlr.2023.100340_bib46","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.30041","article-title":"Fibroblast growth factor 15-dependent and bile acid-independent promotion of liver regeneration in mice","volume":"68","author":"Kong","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jlr.2023.100340_bib47","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1194\/jlr.M007641","article-title":"Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice","volume":"51","author":"Zhang","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib48","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2174\/0929866528666210816114032","article-title":"An overview of 7alpha- and 7beta-hydroxysteroid dehydrogenases: structure, specificity and practical application","volume":"28","author":"Lou","year":"2021","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.jlr.2023.100340_bib49","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1128\/jb.173.7.2173-2179.1991","article-title":"Cloning and sequencing of the 7 alpha-hydroxysteroid dehydrogenase gene from Escherichia coli HB101 and characterization of the expressed enzyme","volume":"173","author":"Yoshimoto","year":"1991","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.jlr.2023.100340_bib50","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/jb.173.15.4558-4569.1991","article-title":"Cloning, sequencing, and expression of the gene coding for bile acid 7 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708","volume":"173","author":"Baron","year":"1991","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.jlr.2023.100340_bib51","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1128\/jb.176.16.4865-4874.1994","article-title":"Characterization and regulation of the NADP-linked 7 alpha-hydroxysteroid dehydrogenase gene from Clostridium sordellii","volume":"176","author":"Coleman","year":"1994","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.jlr.2023.100340_bib52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.jbchem.a122095","article-title":"Purification and characterization of 7 beta-hydroxysteroid dehydrogenase from Ruminococcus sp. of human intestine","volume":"102","author":"Akao","year":"1987","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.jlr.2023.100340_bib53","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0022-2275(20)37894-9","article-title":"Separation of 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers","volume":"24","author":"Macdonald","year":"1983","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-2275(20)34377-7","article-title":"Bile acid induction of 7 alpha- and 7 beta-hydroxysteroid dehydrogenases in Clostridium limosum","volume":"26","author":"Sutherland","year":"1985","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2023.100340_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00394-008-0755-2","article-title":"Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences","volume":"48","author":"Ditscheid","year":"2009","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.jlr.2023.100340_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jlr.2023.100340_bib57","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.jlr.2023.100340_bib58","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to Cholestatic Liver Disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227523000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:32:20Z","timestamp":1758306740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227523000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0022227523000135"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100340","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2023.100340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100340"}}